Daily serum phosphate increase as early and reliable indicator of kidney injury in children with leukemia and lymphoma developing tumor lysis syndrome

[1]  J. Brinton,et al.  Nephrotoxic Exposures and Acute Kidney Injury in Noncritically Ill Children Stratified by Service. , 2022, Hospital pediatrics.

[2]  Ranjit S. Chima,et al.  A Risk Stratified Assessment of Biomarker Based Acute Kidney Injury Phenotypes in Children , 2022, Pediatric Research.

[3]  Hui-bin Huang,et al.  Hyperphosphatemia and Outcomes in Critically Ill Patients: A Systematic Review and Meta-Analysis , 2022, Frontiers in Medicine.

[4]  Ranjit S. Chima,et al.  Integration of the Renal Angina Index and Urine Neutrophil Gelatinase-Associated Lipocalin Improves Severe Acute Kidney Injury Prediction in Critically Ill Children and Young Adults , 2022, Kidney international reports.

[5]  I. Sinescu,et al.  Tumor Lysis Syndrome: An Endless Challenge in Onco-Nephrology , 2022, Biomedicines.

[6]  A. Kouatchet,et al.  Serum phosphate level and its kinetic as an early marker of acute kidney injury in tumor lysis syndrome , 2022, Journal of Nephrology.

[7]  Yulistiani,et al.  Hydration effect on kidney function and serum electrolyte in children with tumor lysis syndrome (TLS) and risk of TLS , 2021, Journal of basic and clinical physiology and pharmacology.

[8]  Chi-kong Li,et al.  Clinical characteristics of tumor lysis syndrome in childhood acute lymphoblastic leukemia , 2021, Scientific Reports.

[9]  Rajit K. Basu,et al.  Recalibration of the Renal Angina Index for Pediatric Septic Shock , 2021, Kidney international reports.

[10]  J. Małyszko,et al.  Prevention and Treatment of Tumor Lysis Syndrome in the Era of Onco-Nephrology Progress , 2020, Kidney and Blood Pressure Research.

[11]  R. Raina,et al.  Changing the terminology from kidney replacement therapy to kidney support therapy , 2020, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[12]  A. Leung,et al.  Tumor lysis syndrome in childhood malignancies , 2020, Drugs in context.

[13]  Andrew A. White,et al.  Comparative effectiveness of rasburicase versus allopurinol for cancer patients with renal dysfunction and hyperuricemia. , 2020, Leukemia research.

[14]  Stephen E. Muething,et al.  A prospective multi-center quality improvement initiative (NINJA) indicates a reduction in nephrotoxic acute kidney injury in hospitalized children. , 2019, Kidney international.

[15]  B. Giraudeau,et al.  Nephrotoxic drug burden among 1001 critically ill patients: impact on acute kidney injury , 2019, Annals of Intensive Care.

[16]  K. Moorani,et al.  Tumor lysis syndrome in pediatric acute lymphoblastic leukemia at tertiary care center , 2019, Pakistan journal of medical sciences.

[17]  T. Habermann,et al.  Impact of early rasburicase on incidence of clinical tumor lysis syndrome in lymphoma , 2019, Leukemia & lymphoma.

[18]  Priyakumari Thankamony,et al.  Risk‐based management strategy and outcomes of tumor lysis syndrome in children with leukemia/lymphoma: Analysis from a resource‐limited setting , 2018, Pediatric blood & cancer.

[19]  Nicole A Herrera,et al.  Comparison of fixed versus traditional weight‐based dosing of rasburicase in a pediatric population , 2018, Pediatric blood & cancer.

[20]  F. Locatelli,et al.  Current and potential treatment options for hyperphosphatemia , 2018, Expert opinion on drug safety.

[21]  Anthony J. Perissinotti,et al.  Rational use of rasburicase for the treatment and management of tumor lysis syndrome , 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[22]  S. Hamlin,et al.  Tumor Lysis Syndrome: A Unique Solute Disturbance. , 2017, The Nursing clinics of North America.

[23]  J. Małyszko,et al.  Nephrotoxicity of anticancer treatment. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  V. Vallon.  Tubular Transport in Acute Kidney Injury: Relevance for Diagnosis, Prognosis and Intervention , 2016, Nephron.

[25]  G. H. Jackson,et al.  Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology , 2015, British journal of haematology.

[26]  Richard J. Johnson,et al.  Uric Acid and the Prediction Models of Tumor Lysis Syndrome in AML , 2015, PloS one.

[27]  P. Moreau,et al.  Tumour lysis syndrome and acute kidney injury in high‐risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco‐Hématologique , 2013, British journal of haematology.

[28]  S. Chevret,et al.  Acute Kidney Injury in Patients with Newly Diagnosed High-Grade Hematological Malignancies: Impact on Remission and Survival , 2013, PloS one.

[29]  D. Mika,et al.  Tumour lysis syndrome: implications for cancer therapy. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[30]  A. El-Husseini,et al.  Acute kidney injury associated with tumor lysis syndrome: a paradigm shift. , 2012, The American journal of emergency medicine.

[31]  H. Shin,et al.  Tumour lysis syndrome in children: experience of last decade , 2011, Hematological oncology.

[32]  M. Elisaf,et al.  Causes and mechanisms of acid-base and electrolyte abnormalities in cancer patients. , 2008, European journal of internal medicine.

[33]  Jaime Herrera-Acosta,et al.  Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. , 2005, Kidney international.

[34]  B. Gobel.  Management of tumor lysis syndrome: prevention and treatment. , 2002, Seminars in oncology nursing.

[35]  M. Elisaf,et al.  Hypokalemia, hypophosphatemia and hypouricemia due to proximal renal tubular dysfunction in acute myeloid leukemia , 2000, European journal of haematology.

[36]  G. van Melle,et al.  Urinary phosphate/creatinine, calcium/creatinine, and magnesium/creatinine ratios in a healthy pediatric population. , 1997, The Journal of pediatrics.

[37]  T. Stukel,et al.  Normal values for random urinary calcium to creatinine ratios in infancy. , 1993, The Journal of pediatrics.

[38]  D. Barnard,et al.  TmP/GFR and Ionized Calcium in the Management of Severe Hypophosphataemia , 1992, Annals of clinical biochemistry.